Paladin Wealth
AZN icon

Paladin Wealth’s AstraZeneca AZN Stock Holding History

Paladin Wealth’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$471K Buy
2,916
+1,259
+76% +$210K 0.25% 103
2026
Q2 		$314K Buy
1,657
+189
+13% +$35.5K 0.18% 110
2026
Q1 		$290K Buy
1,468
+263
+22% +$50.7K 0.2% 112
2025
Q4 		$221K Buy
+1,205
New +$211K 0.15% 118
2024
Q4 		– Sell
-66
Closed -$10.2K – 107
2024
Q3 		$10.2K Buy
+66
New +$10.7K 0.01% 178

Other funds holding AZN

Parnassus Investments
Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Border to Coast Pensions Partnership
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $39.3B AUM 31.81% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return
ASR Vermogensbeheer
ASR Vermogensbeheer Utrecht, Netherlands $10.1B AUM 30.4% 1-Year Est. Return
Generali Asset Management
Generali Asset Management Trieste, Italy $5.73B AUM 29.6% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Paladin Wealth's AZN Position: Q3 2026 in Review

Paladin Wealth increased its AstraZeneca (AZN) stake by 76% in Q3 2026, buying an estimated $210K and bringing the position to 2,916 shares worth $471K. The position accounts for 0.25% of the portfolio, ranked #103.

Paladin Wealth first reported a position in AZN in Q3 2024 and has held it in 5 quarters since. 518 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Paladin Wealth held 2,916 shares of AstraZeneca worth $471K as of Q3 2026.
  • Paladin Wealth bought 1,259 AstraZeneca shares in Q3 2026, an estimated $210K.
  • AstraZeneca made up 0.25% of Paladin Wealth's portfolio in Q3 2026, its #103 holding.
  • Paladin Wealth first reported a position in AstraZeneca in Q3 2024 and has held it in 5 quarters since.
  • 518 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Paladin Wealth's 13F filing for Q3 2026, filed 23 Oct 2026.